Cord tissue is the actual umbilical cord and the cells contained within. It is an abundent source of Mesenchymal Stem Cells (MSCs). Learn more about cord tissue.
Cord tissue stem cells, or Mesenchymal Stem Cells (MSCs), are the “building blocks” of the body’s skeletal and connective tissues. They have also shown the ability to differentiate into coronary tissue, hepatic tissue and more.
Cord blood stem cells are called Hematopoietic Stem Cells (HSCs). The primary focus in research with HSCs has been on blood and immune system disorders.
Researchers have focused their efforts on connective tissue disorders and regenerative medicine with the Mesenchymal Stem Cells (MSCs) derived from cord tissue.
Cord blood and cord tissue yield two vastly different types of stem cells that can potentially be used to treat different diseases and conditions within the body. Learn more.
Cord tissue MSCs have shown great potential in clinical trials for treating many conditions that were previously considered incurable. Over 300 MSC clinical trials are in progress, which demonstrates the importance being placed on this new technology.
Yes. MSCs are immunoprivileged. This means that MSCs can be used to treat any member of your family, with little risk of transplant rejection or GVHD.
No. Currently, there are no public cord blood or tissue banks that will collect, process and store MSCs for future transplant.
Yes. Cord tissue MSCs can be expanded, which multiplies the number of viable stem cells to doses that are suitable for an adult transplant.